Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Kriti Nutrients
Join Channel
Consolidated Standalone

Kriti Nutrients

₹100.6 -1 | 0.9%

Market Cap ₹504 Cr.

Stock P/E 11.1

P/B 2.9

Current Price ₹100.6

Book Value ₹ 35.2

Face Value 1

52W High ₹129.8

Dividend Yield 0.3%

52W Low ₹ 44.6

Edit Ratio

Kriti Nutrients Research see more...

Overview Inc. Year: 1996Industry: Edible Oil

Kriti Nutrients Ltd is engaged in soya seed extraction, and manufacturing and selling of cooking oil under its very own brand KRITI. The Company's number one products encompass soya lecithin flakes and flour, and soya crude oil/subtle oil. It has a manufacturing setup, which incorporates solvent extraction plants, vegetable oil refinery, lecithin plant, effluent remedy plant, fluidized bed boilers and an in-house tin and jar manufacturing facility. It uses non-genetically modified organism (GMO) soyabean seeds with a nutrient content to manufacture a product variety, which incorporates refined soyabean oil, Superhypro meal, Defatted soya flakes and lecithin used for human consumption, cattle feed, poultry, aquaculture, confectionary, dairy product, business packages and pharmaceutical arrangements. Its merchandise additionally encompass soymeal and soya grits. The Company is also engaged in buying and selling sunflower oil. Its soya plant is positioned at Dewas, with a place of approximately 60,520 sq meters.

Read More..

Kriti Nutrients Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Kriti Nutrients Quarterly Results

#(Fig in Cr.) Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Net Sales 239 200 194 200 222 181 212 133 167 172
Other Income 1 1 1 2 1 1 1 1 1 1
Total Income 240 200 195 202 223 182 213 135 168 173
Total Expenditure 231 193 190 193 211 172 194 121 148 159
Operating Profit 9 7 5 9 12 10 19 14 20 14
Interest 1 1 1 1 1 1 1 0 0 0
Depreciation 1 1 1 1 1 1 1 1 1 1
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 7 5 3 7 10 8 17 12 19 12
Provision for Tax 2 2 1 2 2 2 5 3 5 4
Profit After Tax 5 4 2 5 8 6 13 10 14 9
Adjustments 0 0 0 0 -0 0 -0 0 -0 0
Profit After Adjustments 5 4 2 5 8 6 13 10 14 9
Adjusted Earnings Per Share 1 0.7 0.4 1.1 1.5 1.1 2.5 1.9 2.8 1.7

Kriti Nutrients Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 466 288 310 358 457 461 485 520 690 753 797 684
Other Income 1 1 2 1 3 2 1 3 2 3 4 4
Total Income 467 289 312 359 459 462 486 524 693 756 801 689
Total Expenditure 456 276 296 343 442 429 454 497 668 734 766 622
Operating Profit 11 13 16 16 17 33 32 27 25 23 36 67
Interest 6 5 5 5 5 5 2 2 1 2 4 1
Depreciation 3 3 2 2 2 3 3 3 3 4 4 4
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 2 6 9 9 10 25 27 22 20 17 28 60
Provision for Tax 1 2 3 3 3 9 10 3 5 5 7 17
Profit After Tax 1 4 6 6 6 16 17 19 15 12 21 46
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 1 4 6 6 6 16 17 19 15 12 21 46
Adjusted Earnings Per Share 0.2 0.7 1.1 1.3 1.3 3.2 3.4 3.8 3 2.5 4.2 8.9

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 6% 15% 12% 6%
Operating Profit CAGR 57% 10% 2% 13%
PAT CAGR 75% 3% 6% 36%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 112% 32% 32% 39%
ROE Average 17% 15% 19% 20%
ROCE Average 20% 19% 24% 27%

Kriti Nutrients Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 18 22 27 33 38 54 69 87 101 113 132
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 12 8 4 1 0 0 0 0 0 0 0
Other Non-Current Liabilities 7 7 7 7 7 7 8 8 7 7 7
Total Current Liabilities 30 30 41 35 58 50 27 32 16 48 54
Total Liabilities 68 65 78 75 103 111 103 127 124 168 193
Fixed Assets 36 34 35 35 35 40 40 46 44 47 49
Other Non-Current Assets 1 1 1 1 1 1 9 9 15 17 18
Total Current Assets 31 30 43 40 67 69 54 72 65 104 127
Total Assets 68 65 78 75 103 111 103 127 124 168 193

Kriti Nutrients Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 0 0 1 0 1 1 0 3 4
Cash Flow from Operating Activities 7 4 6 12 -18 17 24 13 9 -11 20
Cash Flow from Investing Activities -4 0 -1 -1 -1 -5 -3 -6 1 -20 -3
Cash Flow from Financing Activities -3 -5 -5 -11 18 -11 -21 -9 -7 31 -1
Net Cash Inflow / Outflow 0 -0 -0 0 -0 1 0 -1 3 1 15
Closing Cash & Cash Equivalent 0 0 0 0 0 1 1 0 3 4 19

Kriti Nutrients Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 0.21 0.71 1.15 1.26 1.25 3.15 3.38 3.79 3.01 2.46 4.15
CEPS(Rs) 0.74 1.22 1.59 1.71 1.74 3.67 3.92 4.4 3.69 3.2 4.98
DPS(Rs) 0.06 0.1 0.1 0.12 0.12 0.18 0.18 0.18 0.18 0.18 0.25
Book NAV/Share(Rs) 3.68 4.32 5.31 6.52 7.63 10.68 13.79 17.36 20.16 22.45 26.42
Core EBITDA Margin(%) 2.17 4.19 4.5 4.13 3.08 6.79 6.36 4.56 3.22 2.57 3.91
EBIT Margin(%) 1.83 3.61 4.32 3.83 3.13 6.58 6.02 4.6 3.08 2.52 3.95
Pre Tax Margin(%) 0.45 1.93 2.82 2.56 2.1 5.46 5.52 4.28 2.94 2.24 3.51
PAT Margin (%) 0.23 1.23 1.85 1.75 1.37 3.42 3.49 3.65 2.18 1.63 2.61
Cash Profit Margin (%) 0.79 2.12 2.57 2.39 1.91 3.99 4.05 4.24 2.68 2.13 3.13
ROA(%) 1.68 5.36 8.03 8.2 7.03 14.76 15.84 16.49 11.98 8.42 11.52
ROE(%) 5.9 17.8 23.87 21.23 17.73 34.41 27.65 24.35 16.02 11.53 16.99
ROCE(%) 25.81 26.78 30.51 29.26 23.89 38.91 35.48 27.43 21.76 15.19 19.8
Receivable days 3.11 5.24 6.34 6.22 7.92 10.75 9.6 12.5 8.4 5.05 5.54
Inventory Days 10.97 24.11 27.15 25.86 25.12 29.1 23.35 20.81 18.23 21.35 26.49
Payable days 17.25 27.27 23.22 20.33 14.84 12.37 8.74 7 4.16 3.77 3.47
PER(x) 17.63 4.51 5 12.3 16.1 14.84 9.06 3.98 13.18 24.25 9.12
Price/Book(x) 1.01 0.74 1.08 2.37 2.65 4.38 2.22 0.87 1.96 2.65 1.43
Dividend Yield(%) 1.62 3.12 1.74 0.78 0.59 0.39 0.59 1.19 0.45 0.3 0.66
EV/Net Sales(x) 0.07 0.12 0.15 0.25 0.29 0.57 0.34 0.15 0.28 0.43 0.26
EV/Core EBITDA(x) 3.09 2.63 3.01 5.61 7.99 7.96 5.15 2.96 7.88 14.43 5.78
Net Sales Growth(%) 2.06 -38.14 7.6 15.31 27.55 0.91 5.33 7.24 32.61 9.1 5.84
EBIT Growth(%) -44.06 22.03 28.76 2.15 4.22 111.93 -3.8 -17.94 -11.41 -10.76 66.15
PAT Growth(%) -73.48 238.86 61.55 9.29 -0.13 151.15 7.38 12.12 -20.78 -18.27 69.02
EPS Growth(%) -73.48 238.92 61.55 9.29 -0.13 151.15 7.38 12.12 -20.78 -18.28 69.02
Debt/Equity(x) 1 0.91 0.76 0.44 0.91 0.55 0.18 0.07 0.01 0.31 0.29
Current Ratio(x) 1.02 1.01 1.04 1.14 1.16 1.37 2.03 2.22 4.14 2.16 2.37
Quick Ratio(x) 0.42 0.34 0.4 0.44 0.5 0.68 1.01 1.23 1.82 1.09 1.17
Interest Cover(x) 1.33 2.15 2.87 3.01 3.03 5.86 12.09 14.11 22.61 8.99 8.91
Total Debt/Mcap(x) 0.99 1.22 0.7 0.18 0.34 0.13 0.08 0.08 0 0.12 0.2

Kriti Nutrients Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 66.36 66.37 66.37 66.37 66.37 66.37 66.66 66.66 66.68 66.68
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 33.63 33.63 33.63 33.63 33.63 33.63 33.33 33.33 33.31 33.31
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Debtor days have improved from 3.77 to 3.47days.
  • Company is almost debt free.

Cons

  • The company has delivered a poor profit growth of 5% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Kriti Nutrients News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!